Celldex Presents Promising Data from CDX-0159 and CDX-527 Programs

HAMPTON, N.J., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) presented data from the Companys preclinical pipeline this weekend.